We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$678M
AUM Growth
-$129M
Cap. Flow
-$178M
Cap. Flow %
-26.18%
Top 10 Hldgs %
21.1%
Holding
174
New
44
Increased
23
Reduced
49
Closed
45

Top Sells

Rank Stock Value
1
ASAN icon
Asana
ASAN
+$17.4M
2
CDNA icon
CareDx
CDNA
+$14.9M
3
SGRY icon
Surgery Partners
SGRY
+$11.8M
4
AZTA icon
Azenta
AZTA
+$11.5M
5
SITM icon
SiTime
SITM
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 31.4%
2 Healthcare 21.09%
3 Industrials 17.66%
4 Consumer Discretionary 15.18%
5 Financials 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRL icon
76
Charles River Laboratories
CRL
$12.7B
$3.65M 0.54%
8,845
+1,725
+24% +$716K
EXTR icon
77
Extreme Networks
EXTR
$3.16B
$3.63M 0.53%
368,085
-350,525
-49% -$3.7M
TREX icon
78
Trex
TREX
$5.03B
$3.52M 0.52%
34,485
DIOD icon
79
Diodes
DIOD
$4.73B
$3.45M 0.51%
38,100
-10,455
-22% -$913K
MIDD icon
80
Middleby
MIDD
$6.07B
$3.43M 0.51%
20,140
+11,400
+130% +$2.06M
RVLV icon
81
Revolve Group
RVLV
$1.77B
$3.39M 0.5%
54,825
-103,820
-65% -$6.76M
SPSC icon
82
SPS Commerce
SPSC
$2.66B
$3.37M 0.5%
+20,865
New +$2.57M
FANG icon
83
Diamondback Energy
FANG
$52.3B
$3.17M 0.47%
33,455
BCRX icon
84
BioCryst Pharmaceuticals
BCRX
$2.39B
$3.15M 0.46%
219,450
-122,735
-36% -$1.94M
HZNP
85
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.14M 0.46%
28,645
SKIN icon
86
SkinHealth Systems
SKIN
$88.3M
$3.13M 0.46%
120,405
+53,455
+80% +$1.18M
LOVE
87
LoveSac
LOVE
$258M
$3M 0.44%
45,445
-16,030
-26% -$1M
APPS icon
88
Digital Turbine
APPS
$1.73B
$2.9M 0.43%
42,220
+1,600
+4% +$99.2K
MGY icon
89
Magnolia Oil & Gas
MGY
$5.94B
$2.85M 0.42%
160,265
-50,140
-24% -$758K
ENTG icon
90
Entegris
ENTG
$22.5B
$2.84M 0.42%
22,530
NTLA icon
91
Intellia Therapeutics
NTLA
$1.67B
$2.83M 0.42%
21,085
-12,385
-37% -$1.88M
CRNC icon
92
Cerence
CRNC
$404M
$2.77M 0.41%
+28,865
New +$3.15M
LFUS icon
93
Littelfuse
LFUS
$11.7B
$2.75M 0.41%
10,060
+2,500
+33% +$666K
FND icon
94
Floor & Decor
FND
$6.61B
$2.6M 0.38%
+21,545
New +$2.57M
MEDP icon
95
Medpace
MEDP
$16.4B
$2.52M 0.37%
+13,315
New +$2.43M
EFOR
96
Everforth Inc
EFOR
$1.34B
$2.51M 0.37%
+22,195
New +$2.34M
PLNT icon
97
Planet Fitness
PLNT
$4B
$2.51M 0.37%
+31,960
New +$2.43M
FORG
98
DELISTED
ForgeRock, Inc.
FORG
$2.49M 0.37%
+63,960
New +$2.69M
DDD icon
99
3D Systems Corp
DDD
$595M
$2.47M 0.36%
89,705
-123,180
-58% -$3.65M
FIVE icon
100
Five Below
FIVE
$12.9B
$2.46M 0.36%
13,900
+3,745
+37% +$746K

Similar funds

Lisanti Capital Growth's Q3 2021 Portfolio in Review

As of Q3 2021, Lisanti Capital Growth held 174 positions worth $678M, down 16% from $808M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lisanti Capital Growth withdrew a net $178M in Q3 2021, closing 45 positions and reducing 49 holdings. Its most notable exit was CareDx, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Biohaven Pharmaceutical Holding Company Ltd. worth $11.8M.

  • Lisanti Capital Growth's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 85,280 shares worth $11.8M.
  • Lisanti Capital Growth added most to Allegiant Air in Q3 2021, an estimated $3.11M increase.
  • Lisanti Capital Growth's biggest Q3 2021 reduction was Asana, cutting an estimated $17.4M.
  • Lisanti Capital Growth fully exited CareDx in Q3 2021, selling an estimated $14.9M.
  • Lisanti Capital Growth's ten largest holdings make up 21% of its $678M portfolio in Q3 2021.
  • Lisanti Capital Growth opened 44 new positions and closed 45 in Q3 2021.
  • Lisanti Capital Growth's portfolio value fell 16% quarter-over-quarter to $678M.

Based on Lisanti Capital Growth's 13F filing for Q3 2021, filed 3 Nov 2021.